Disease/Infection News

RSS

Not all HIV viruses are bad for the immune system

Mayo Clinic researchers have shown why, in a minority of HIV patients, immune function improves despite a lack of response to standard anti-retroviral treatment. In these cases, researchers say, the virus has lost its ability to kill immune cells. The findings appear in the online journal PLoS Pathogens.

1 Dec 2010

Black rice may help soothe inflammation: Research

The latest episode in the American Chemical Society's (ACS) award-winning podcast series, "Global Challenges/Chemistry Solutions," focuses on the discovery that black rice a little-known variety of the grain that is the staple food for one-third of the world's population may help soothe the inflammation involved in allergies, asthma and other diseases.

1 Dec 2010

Anacor, UCSF and NYBC collaborate to discover drug therapies for river blindness

Anacor Pharmaceuticals, the University of California San Francisco (UCSF) Sandler Center and the Lindsley F. Kimball Research Institute (LFKRI) of the New York Blood Center (NYBC) today announced the establishment of a research and development collaboration to discover new drug therapies for the treatment of river blindness (onchocerciasis), a parasitic disease that is the second leading cause of infectious blindness worldwide, and is most prevalent in Africa.

1 Dec 2010

Bill & Melinda Gates Foundation awards $6M grant to NanoBio to develop intranasal vaccine for RSV

NanoBio Corporation announced today that it has received a $6M grant from the Bill & Melinda Gates Foundation to support the development of a safe and effective intranasal vaccine for Respiratory Syncytial Virus (RSV).

1 Dec 2010

PhRMA reports 100 new medicines and vaccines in development for HIV/AIDS

America's biopharmaceutical research companies are working on 100 new medicines and vaccines [video] to treat and prevent HIV/AIDS and related conditions, according to a new report from the Pharmaceutical Research and Manufacturers of America (PhRMA).

1 Dec 2010

Washington State Hospital Association makes public surgical infection rates

Today, the Washington State Hospital Association is releasing hospital-specific surgical infection rate data. This is the first time this information has been made public.

1 Dec 2010

Number of people living with HIV/AIDS in Africa to outpace treatment resources by 2020, IOM report finds

The number of people living with HIV/AIDS in Africa is projected to greatly outpace treatment resources by the end of the decade, according to a report released Monday by the Institute of Medicine (IOM), Reuters reports (Fox, 11/29).

1 Dec 2010

Research on patients' immune system may lead to new diagnostic tool for HIV treatment

1 Dec 2010

Research shows anti-microbial medications lead to acute liver failure

New research shows that anti-microbial medications are a common cause of drug-induced liver injury (DILI) leading to acute liver failure (ALF), with women and minorities disproportionately affected.

1 Dec 2010

Goosby, Emanuel address progress, potential roadblocks ahead for introduction of microbicides in developing countries

The growing evidence supporting the promise of new HIV prevention products, like microbicides, requires that groups start planning now for how best to roll-out prevention interventions in the future, U.S. Global AIDS Coordinator Eric Goosby and Special Advisor on Health Policy to the Director of the White House Office of Management and Budget Ezekiel Emanuel said Monday during a USAID Microbicide Stakeholders Meeting in Washington.

30 Nov 2010

Argos commences dosing in Arcelis personalized immunotherapy Phase 2b clinical trial for HIV

Argos Therapeutics today announced that it has initiated dosing of patients in a Phase 2b clinical trial of its Arcelis™ personalized immunotherapy for the treatment of HIV patients, AGS-004.

30 Nov 2010

Opinions: Obama's Global Fund pledge; harm reduction in Iran; HIV prevention; African development

There are some encouraging signs in the epic battle against AIDS and HIV infections. But those bright spots dim considerably in the face of the fact that about 7,100 people a day become infected.

30 Nov 2010

HIV testing rates rise among Americans

A U.S. government report released Tuesday says that a record number of Americans are getting tested for HIV but more than 200,000 Americans are infected and are unaware of their status. In 2009 82.9 million adults age 18 to 64 had been tested for HIV. This is 11.4 million more than the total in 2006. Also until 2009 45 percent of adults had been tested at least once in their lives, up from 40 percent four years ago. However 55 percent of adults, and 28.3 percent of adults at risk for HIV, have never been tested, according to the report.

30 Nov 2010

Gavi Alliance elects new chair to continue global immunisation efforts

Former Norwegian Minister of Health and current member of parliament Dagfinn Høybråten was unanimously elected by the GAVI Alliance Board as its new Chair, GAVI announced on the first day of its board meeting taking place in Kigali, the capital of Rwanda.

30 Nov 2010

Canadians at increased risk for flu complications not aware of all the facts

It starts with a headache, chills or that all-over-achy feeling. It comes on quickly, yet too many Canadians ignore the rapid onset of flu symptoms. But for the millions of Canadians at increased risk for developing serious complications from the flu, including people 65 and older, pregnant women and those with chronic medical conditions like chronic obstructive pulmonary disease (COPD), asthma, heart disease and diabetes, this 'laissez faire' attitude could be putting their health in jeopardy.

30 Nov 2010

Pharmasset commences combination study of PSI-7977 and PSI-938 nucleotide analogs in HCV

Pharmasset, Inc. announced today that dosing has begun in Part 2 of a Phase 1 study. This is the first clinical study combining a purine (PSI-938) and a pyrimidine (PSI-7977) nucleotide analog for HCV, and is designed to evaluate once daily doses of PSI-7977 and PSI-938 in patients with HCV who have not been treated previously.

30 Nov 2010

AIDS Healthcare Foundation to participate in Members Project

AIDS Healthcare Foundation (AHF) is proud to be selected as a candidate charity in Members Project, a partnership between American Express and TakePart.

30 Nov 2010

Emergency artesunate suppositories are cost-effective intervention for children with suspected severe malaria

Giving emergency artesunate suppositories to children with suspected severe malaria before referring them for treatment is a cost-effective intervention that can substantially improve the management of childhood malaria in remote African settings, according to a new study led by Boston University School of Public Health [BUSPH] researcher Yesim Tozan, PhD.

30 Nov 2010

American Red Cross announces additional $2 million to combat cholera epidemic in Haiti

The American Red Cross announced today it is committing an additional $2 million to combat an escalating cholera epidemic in Haiti that has killed more than 1,700 people and sickened more than 75,000.

30 Nov 2010

GeoVax supports Bionor's Phase 2b trial of therapeutic HIV/AIDS vaccine

GeoVax Labs, Inc., an Atlanta-based, biopharmaceutical company developing human vaccines for HIV/AIDS (HIV-1, Human Immunodeficiency Virus), announced it was pleased to learn of the partial success observed in the recently completed Phase 2b trial of a therapeutic HIV/AIDS vaccine produced by Bionor Immuno AS of Oslo, Norway.

30 Nov 2010

Disease/Infection News

Not all HIV viruses are bad for the immune system

Black rice may help soothe inflammation: Research

Anacor, UCSF and NYBC collaborate to discover drug therapies for river blindness

Bill & Melinda Gates Foundation awards $6M grant to NanoBio to develop intranasal vaccine for RSV

PhRMA reports 100 new medicines and vaccines in development for HIV/AIDS

Washington State Hospital Association makes public surgical infection rates

Number of people living with HIV/AIDS in Africa to outpace treatment resources by 2020, IOM report finds

Research on patients' immune system may lead to new diagnostic tool for HIV treatment

Research shows anti-microbial medications lead to acute liver failure

Goosby, Emanuel address progress, potential roadblocks ahead for introduction of microbicides in developing countries

Argos commences dosing in Arcelis personalized immunotherapy Phase 2b clinical trial for HIV

Opinions: Obama's Global Fund pledge; harm reduction in Iran; HIV prevention; African development

HIV testing rates rise among Americans

Gavi Alliance elects new chair to continue global immunisation efforts

Canadians at increased risk for flu complications not aware of all the facts

Pharmasset commences combination study of PSI-7977 and PSI-938 nucleotide analogs in HCV

AIDS Healthcare Foundation to participate in Members Project

Emergency artesunate suppositories are cost-effective intervention for children with suspected severe malaria

American Red Cross announces additional $2 million to combat cholera epidemic in Haiti

GeoVax supports Bionor's Phase 2b trial of therapeutic HIV/AIDS vaccine

How can super-resolution technology help study neurotransmission?

The Proteoform Puzzle: Unlocking the Next Frontier

Synthetic Biology and the Pursuit of Living Diagnostics

Latest News